Interpace Biosciences Announces First Quarter 2020 Financial and Business Results
First Quarter Net Revenue Improved Over 53% to $9.2 MillionLaunching COVID-19 Serology TestingContinues to Integrate Service Offerings and Streamline CostsConference […]